Phytopharm has announced results of its Phase II, randomised trial of Cogane in unmedicated patients with Parkinson's disease. More than four hundred subjects with early-stage Parkinson's disease were randomly chosen to receive either ...
Tags: PhytopharmPhase II, randomised trial, Parkinson's disease